Cargando…

Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex®) in Diabetic Patients with Coexisting Cataract and Diabetic Macular Edema

PURPOSE: To investigate the effectiveness and safety of combined phacoemulsification and dexamethasone intravitreal implant in patients with cataract and diabetic macular edema. METHODS: In this two-center, retrospective, single-group study, the charts of 16 consecutive patients who underwent combin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Furino, Claudio, Boscia, Francesco, Niro, Alfredo, Giancipoli, Ermete, Grassi, Maria Oliva, D'amico Ricci, Giuseppe, Blasetti, Francesco, Reibaldi, Michele, Alessio, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572607/ https://www.ncbi.nlm.nih.gov/pubmed/28884024 http://dx.doi.org/10.1155/2017/4896036

Ejemplares similares

DIABETIC MACULAR EDEMA AND CATARACT SURGERY: Phacoemulsification Combined With Dexamethasone Intravitreal Implant Compared With Standard Phacoemulsification
por: Furino, Claudio, et al.
Publicado: (2021)

Efficacy of Intravitreal Dexamethasone Implant in Different Patterns of Diabetic Macular Edema
por: Furino, Claudio, et al.
Publicado: (2020)

Intravitreal Therapy for Diabetic Macular Edema: An Update
por: Furino, Claudio, et al.
Publicado: (2021)

Intravitreal Dexamethasone in Patients with Wet Age-Related Macular Degeneration Resistant to Anti-VEGF: A Prospective Pilot Study
por: Giancipoli, Ermete, et al.
Publicado: (2018)

Preliminary results of an intravitreal dexamethasone implant (Ozurdex®) in patients with persistent diabetic macular edema
por: Pacella, Elena, et al.
Publicado: (2013)

Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
por: Castro-Navarro, Verónica, et al.
Publicado: (2019)

Intravitreal Dexamethasone Implant (Ozurdex) in Coats’ Disease
por: Saatci, Ali Osman, et al.
Publicado: (2013)

Intravitreal Injections in Arc Sterile Setting: Safety Profile after More Than 10,000 Treatments
por: Furino, Claudio, et al.
Publicado: (2020)

Fractured dexamethasone implant (OZURDEX®) following intravitreal injection
por: Aljohani, Saud M., et al.
Publicado: (2021)

Intravitreal Dexamethasone Implant (Ozurdex) for Refractory Macular Edema Secondary to Retinitis Pigmentosa
por: Örnek, Nurgül, et al.
Publicado: (2016)

A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®)
por: Eris, Erdem, et al.
Publicado: (2017)

Short-term results of intravitreal dexamethasone implant (OZURDEX(®)) in treatment of recalcitrant diabetic macular edema: A case series
por: Rishi, Pukhraj, et al.
Publicado: (2012)

Mid-term safety and effectiveness of macular peeling one month after intravitreal dexamethasone implant for tractional diabetic macular edema
por: Pignatelli, Francesco, et al.
Publicado: (2023)

Choriocapillaris Reperfusion in Resolved Chronic Central Serous Chorioretinopathy Treated with Eplerenone: Long-Term Effects on the Fellow Eye
por: Viggiano, Pasquale, et al.
Publicado: (2023)

Visual functional changes after ocriplasmin injection for vitreomacular traction: A microperimetric analysis
por: Furino, Claudio, et al.
Publicado: (2020)

Dexamethasone Intravitreal Implant (Ozurdex) for Long-Term Macular Edema after Epiretinal Membrane Peeling Surgery
por: Chang, Yo-Chen, et al.
Publicado: (2018)

Modified insertion technique for a sustained-release dexamethasone intravitreal implant (Ozurdex®)
por: Lee, Daniel H., et al.
Publicado: (2020)

Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex(®) Outcomes
por: Udaondo, Patricia, et al.
Publicado: (2021)

Morphology and Function over a One-Year Follow Up Period after Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema
por: Mastropasqua, Rodolfo, et al.
Publicado: (2015)

Dexamethasone intravitreal implant in the treatment of diabetic macular edema
por: Dugel, Pravin U, et al.
Publicado: (2015)

Five-Month Observation of Persistent Diabetic Macular Edema after Intravitreal Injection of Ozurdex Implant
por: Zalewski, Dominik, et al.
Publicado: (2014)

Evaluation of the Effect of Intravitreal Dexamethasone (Ozurdex(®)) Implant on Intraocular Pressure in Vitrectomized and Non-Vitrectomized Eyes with Macular Edema
por: Garlı, Murat, et al.
Publicado: (2021)

Analysis of Morphologic and Functional Outcomes in Macular Edema due to Central Retinal Vein Occlusion Treated with Intravitreal Dexamethasone Implant
por: Niro, Alfredo, et al.
Publicado: (2018)

Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment
por: Garweg, Justus G., et al.
Publicado: (2016)

Can the dexamethasone intravitreal implant Ozurdex be safely administered in an out-of-operating room setting?
por: Cidad-Betegón, María del Pino, et al.
Publicado: (2020)

Intravitreal Injection of Ozurdex(®) Implant in Patients with Persistent Diabetic Macular Edema, with Six-Month Follow-Up
por: Pacella, Fernanda, et al.
Publicado: (2016)

Results of intravitreal dexamethasone implant (Ozurdex(®)) for retinal vascular diseases with macular edema: An observational study of real-life situations
por: Jirarattanasopa, Pichai, et al.
Publicado: (2022)

Adult Coats’ Disease Successfully Managed with the Dexamethasone Intravitreal Implant (Ozurdex®) Combined with Retinal Photocoagulation
por: Martínez-Castillo, Sebastián, et al.
Publicado: (2012)

Use of an Intravitreal Dexamethasone Implant (Ozurdex) in a Case with Accidental Foveal Photocoagulation by Alexandrite Laser
por: Bulut, Muhammed Nurullah, et al.
Publicado: (2016)

Spectral domain optical coherence tomography changes following intravitreal dexamethasone implant, Ozurdex(®) in patients with uveitic cystoid macular edema
por: Bansal, Pooja, et al.
Publicado: (2015)

Combined Phacoemulsification and Intravitreal Dexamethasone Is an Effective Option for High-Risk Diabetic Macula Oedema Patients
por: Thirunavukarasu, Arun J, et al.
Publicado: (2021)

Macular Oedema Related to Idiopathic Macular Telangiectasia Type 1 Treated with Dexamethasone Intravitreal Implant (Ozurdex)
por: Loutfi, Mohamed, et al.
Publicado: (2014)

Ozurdex (dexamethasone intravitreal implant) for the treatment of intermediate, posterior, and panuveitis: a systematic review of the current evidence
por: Saincher, Saanwalshah Samir, et al.
Publicado: (2020)

Effect of dexamethasone intravitreal implant (Ozurdex®) on corneal endothelium in retinal vein occlusion patients: Corneal endothelium after dexamethasone implant injection
por: Güler, Hatice Ayhan, et al.
Publicado: (2018)

Comparison of Two Anesthetic Methods for Intravitreal Ozurdex Injection
por: Karabaş, V. Levent, et al.
Publicado: (2015)

Secondary glaucoma after intravitreal dexamethasone implant (Ozurdex) injection in patients with retinal disorder: A retrospective study
por: Sweta, VD, et al.
Publicado: (2022)

Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and Late-stage Age-Related Macular Degeneration
por: Pinna, Antonio, et al.
Publicado: (2019)

Inverted internal limiting membrane-flap technique for large macular hole: a microperimetric study
por: Sborgia, Giancarlo, et al.
Publicado: (2019)

Splitting of a Dexamethasone Implant (Ozurdex) following the Injection
por: Donmez, Oya, et al.
Publicado: (2013)

The nomadic Ozurdex(®): Anterior migration of the dexamethasone implant and back!
por: Srinivasan, Priya, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ffg79o8334n58mivcsioo4kfrp